Introducing GPT-Rosalind for life sciences research
Today, we’re introducing GPT‑Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine. The life sciences model series is optimized for scientific workflows, combining improved tool use with deeper understanding across chemistry, protein engineering, and genomics.On average, it takes roughly 10 to 15 years to go from target discovery to regulatory approval for a new drug in the United States. Gains made at the earliest stages of d...
Read more at openai.com